These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 3259465
1. Modulation of a high molecular weight form of transforming growth factor-alpha in human colon carcinoma cell lines. Watkins LF, Brattain MG, Levine AE. Cancer Lett; 1988 May; 40(1):59-70. PubMed ID: 3259465 [Abstract] [Full Text] [Related]
2. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta. Chakrabarty S, Jan Y, Brattain MG, Tobon A, Varani J. Cancer Res; 1989 Apr 15; 49(8):2112-7. PubMed ID: 2539253 [Abstract] [Full Text] [Related]
3. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line. Levine AE, Black B, Brattain MG. J Cell Physiol; 1989 Mar 15; 138(3):459-66. PubMed ID: 2925796 [Abstract] [Full Text] [Related]
4. Human colon cancer cell lines secrete alpha TGF-like activity. Hanauske AR, Buchok J, Scheithauer W, Von Hoff DD. Br J Cancer; 1987 Jan 15; 55(1):57-9. PubMed ID: 3493023 [No Abstract] [Full Text] [Related]
5. N,N-dimethylformamide-induced synthesis of an anti-fibronectin reactive protein in cultured human colon carcinoma cells. Marks ME, Ziober BL, Brattain MG. Cancer Res; 1986 Oct 15; 46(10):5248-58. PubMed ID: 3756877 [Abstract] [Full Text] [Related]
6. Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line. Hoosein NM, Brattain DE, McKnight MK, Levine AE, Brattain MG. Cancer Res; 1987 Jun 01; 47(11):2950-4. PubMed ID: 3471320 [Abstract] [Full Text] [Related]
7. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells. Zipfel PA, Ziober BL, Morris SL, Mulder KM. Cell Growth Differ; 1993 Aug 01; 4(8):637-45. PubMed ID: 8398905 [Abstract] [Full Text] [Related]
8. Transforming growth factor-beta 2 is an autocrine growth inhibitory factor for the MOSER human colon carcinoma cell line. Levine AE, Lewis LR. Cancer Lett; 1993 Jan 15; 68(1):33-41. PubMed ID: 8422647 [Abstract] [Full Text] [Related]
9. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta. Chakrabarty S, Tobon A, Varani J, Brattain MG. Cancer Res; 1988 Jul 15; 48(14):4059-64. PubMed ID: 3289738 [Abstract] [Full Text] [Related]
10. Differential role of transforming growth factor-alpha in two human colon-carcinoma cell lines. Watkins LF, Levine AE. Int J Cancer; 1991 Feb 01; 47(3):455-60. PubMed ID: 1993555 [Abstract] [Full Text] [Related]
11. Growth factor production by human colon carcinoma cell lines. Anzano MA, Rieman D, Prichett W, Bowen-Pope DF, Greig R. Cancer Res; 1989 Jun 01; 49(11):2898-904. PubMed ID: 2541895 [Abstract] [Full Text] [Related]
12. Production of transforming growth factors by human colon cancer lines. Coffey RJ, Shipley GD, Moses HL. Cancer Res; 1986 Mar 01; 46(3):1164-9. PubMed ID: 3002610 [Abstract] [Full Text] [Related]
13. Proliferation of human colon cancer cells: role of epidermal growth factor and transforming growth factor alpha. Huang S, Trujillo JM, Chakrabarty S. Int J Cancer; 1992 Dec 02; 52(6):978-86. PubMed ID: 1459740 [Abstract] [Full Text] [Related]
14. Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line. Mulder KM, Ramey MK, Hoosein NM, Levine AE, Hinshaw XH, Brattain DE, Brattain MG. Cancer Res; 1988 Dec 15; 48(24 Pt 1):7120-5. PubMed ID: 3191488 [Abstract] [Full Text] [Related]
15. Involvement of protein kinase C and an elastase-like enzyme in the processing of transforming growth factor-alpha in human colon carcinoma cell lines. Levine AE. Int J Cancer; 1994 Jul 01; 58(1):129-34. PubMed ID: 8014008 [Abstract] [Full Text] [Related]
16. Comparison of the antiproliferative effects of transforming growth factor-beta, N,N-dimethylformamide and retinoic acid on a human colon carcinoma cell line. Hoosein NM, Brattain DE, McKnight MK, Childress KE, Chakrabarty S, Brattain MG. Cancer Lett; 1988 Jun 15; 40(2):219-32. PubMed ID: 3164250 [Abstract] [Full Text] [Related]
17. Identification of endogenous inhibitory growth factors from a human colon carcinoma cell line. Levine AE, McRae LJ, Hamilton DA, Brattain DE, Yeoman LC, Brattain MG. Cancer Res; 1985 May 15; 45(5):2248-54. PubMed ID: 3857117 [Abstract] [Full Text] [Related]
18. Autonomous proliferation of colon cancer cells that coexpress transforming growth factor alpha and its receptor. Variable effects of receptor-blocking antibody. Karnes WE, Walsh JH, Wu SV, Kim RS, Martin MG, Wong HC, Mendelsohn J, Park JG, Cuttitta F. Gastroenterology; 1992 Feb 15; 102(2):474-85. PubMed ID: 1732118 [Abstract] [Full Text] [Related]
19. Loss of epidermal growth factor receptors and release of transforming growth factors do not correlate with sarcoma virus-transformation in clonally-related NIH/3T3-derived cell lines. Brown KD, Blakeley DM, Roberts P, Avery RJ. Biochem J; 1985 Jul 01; 229(1):119-25. PubMed ID: 2994627 [Abstract] [Full Text] [Related]
20. Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET. Lynch MJ, Pelosi L, Carboni JM, Merwin J, Coleman K, Wang RC, Lin PF, Henry DL, Brattain MG. Cancer Res; 1993 Sep 01; 53(17):4041-7. PubMed ID: 8358733 [Abstract] [Full Text] [Related] Page: [Next] [New Search]